ArticleOncotarget2019

Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma.

Omkara Lakshmi Veeranki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.